  See all
 |
Articles: BMT/SCT |
Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials
Bone Marrow Transplantation, 07/01/09
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies
Bone Marrow Transplantation, 07/01/09 Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention
Bone Marrow Transplantation, 07/01/09 Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection
Bone Marrow Transplantation, 07/01/09 Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation
Cancer, 07/01/09 Mental status changes after hematopoietic stem cell transplantation
Cancer, 06/30/09 Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide, lenalidomide or bortezomib- containing regimens
Blood, 06/29/09 Increased serum levels of matrix metalloproteinase-9 in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
International Journal of Hematology, 06/26/09 Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkins lymphoma
Investigational New Drugs, 06/26/09
Free full text
Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization
Bone Marrow Transplantation, 06/24/09 Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant
American Journal of Hematology, 06/24/09 Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding
Genes, Chromosomes and Cancer, 06/23/09 Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen
Bone Marrow Transplantation, 06/23/09
Exclusive Author Commentary 5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation, 06/23/09 T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft
Bone Marrow Transplantation, 06/23/09 Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT
Bone Marrow Transplantation, 06/23/09 Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study
Bone Marrow Transplantation, 06/23/09 Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation
Blood, 06/22/09 Thrombotic complications after haematopoietic stem cell transplantation: early and late effects
Best Practice & Research: Clinical Haematology, 06/18/09 Reduced intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium (PBMTC) study ONC0313
Blood, 06/18/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
